Home > Diseases and Conditions > Heart attack

Recommended reading: The signs of a heart attack

Some people first find out they have a heart problem when they have a heart attack. Often though, people who have heart attacks have already had coronary artery disease for years. This causes recurring pain in the chest called angina or shortness of breath during exercise or exertion.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.

A.D.A.M. Medical Encyclopedia.

Heart attack

Myocardial infarction; MI; Acute MI; ST-elevation myocardial infarction; Non-ST-elevation myocardial infarction

Last reviewed: June 22, 2012.

A heart attack occurs when blood flow to a part of your heart is blocked for a long enough time that part of the heart muscle is damaged or dies. The medical term for this is myocardial infarction.

Acute MI

Causes, incidence, and risk factors

Most heart attacks are caused by a blood clot that blocks one of the coronary arteries. The coronary arteries bring blood and oxygen to the heart. If the blood flow is blocked, the heart is starved of oxygen and heart cells die.

A hard substance called plaque can build up in the walls of your coronary arteries. This plaque is made up of cholesterol and other cells.

Progressive build-up of plaque in coronary artery

A heart attack may occur when:

  • Blood platelets stick to tears in the plaque and form a blood clot that blocks blood from flowing to the heart. This is the most common cause of heart attacks.
  • A slow buildup of this plaque may almost block one of your coronary arteries.

The cause of heart attacks is not always known. Heart attacks may occur:

  • When you are resting or asleep
  • After a sudden increase in physical activity
  • When you are active outside in cold weather
  • After sudden, severe emotional or physical stress, including an illness

Many risk factors may lead to a heart attack.

Symptoms

A heart attack is a medical emergency. If you have symptoms of a heart attack, call 911 or your local emergency number quickly.

  • DO NOT try to drive yourself to the hospital.
  • DO NOT WAIT. You are at greatest risk of sudden death in the early hours of a heart attack.

Chest pain is the most common symptom of a heart attack. You may feel the pain in only one part of your body, or it may move from your chest to your arms, shoulder, neck, teeth, jaw, belly area, or back.

Heart attack symptoms

The pain can be severe or mild. It can feel like:

  • A tight band around the chest
  • Something heavy sitting on your chest
  • Squeezing or heavy pressure

The pain usually lasts longer than 20 minutes. Rest and a medicine called nitroglycerin may not completely relieve the pain of a heart attack. Symptoms may also go away and come back.

Other symptoms of a heart attack can include:

Some people (the elderly, people with diabetes, and women) may have little or no chest pain. Or, they may have unusual symptoms (shortness of breath, fatigue, and weakness). A "silent heart attack" is a heart attack with no symptoms.

Signs and tests

A doctor or nurse will perform a physical exam and listen to your chest using a stethoscope.

  • The doctor may hear abnormal sounds in your lungs (called crackles), a heart murmur, or other abnormal sounds.
  • You may have a fast or uneven pulse.
  • Your blood pressure may be normal, high, or low.

You will have an electrocardiogram (ECG) to look for heart damage. A troponin blood test can show if you have heart tissue damage. This test can confirm that you are having a heart attack.

Coronary angiography may be done right away or when you are more stable.

  • This test uses a special dye and x-rays to see how blood flows through your heart.
  • It can help your doctor decide which treatments you need next.

Other tests to look at your heart that may be done while you are in the hospital:

Treatment

In the emergency room:

  • You will be hooked up to a heart monitor, so the health care team can look at how your heart is beating.
  • You will receive oxygen so that your heart doesn't have to work as hard.
  • An intravenous line (IV) will be placed into one of your veins. Medicines and fluids pass through this IV.
  • You may get nitroglycerin and morphine to help reduce chest pain.
  • You may receive aspirin, unless it would not be safe for you. In that case, you will be given another medicine that prevents blood clots.
  • Dangerous abnormal heartbeats (arrhythmias) may be treated with medicine or electric shocks.

EMERGENCY TREATMENTS

Angioplasty is a procedure to open narrowed or blocked blood vessels that supply blood to the heart.

  • Angioplasty is often the first choice of treatment. It should be done within 90 minutes after you get to the hospital, and no later than 12 hours after a heart attack.
  • A stent is a small, metal mesh tube that opens up (expands) inside a coronary artery. A stent is often placed after angioplasty. It helps prevent the artery from closing up again.

You may be given drugs to break up the clot. It is best if these drugs are given within 3 hours of when you first felt the chest pain. This is called thrombolytic therapy.

Some patients may also have heart bypass surgery to open narrowed or blocked blood vessels that supply blood to the heart. This procedure is also called open heart surgery.

AFTER YOUR HEART ATTACK

After several days, you will be discharged from the hospital.

You will likely need to take medicines, possibly for the rest of your life. Always talk to your health care provider before stopping or changing how you take any medicines.

While under the care of your health care team, you will learn:

  • How to take medicines to treat your heart problem and prevent more heart attacks
  • How to eat a heart-healthy diet
  • What to do when you have chest pain 
  • How to stop smoking

After a heart attack, you may feel sad. You may feel anxious and worry about being careful about everything you do. All of these feelings are normal. They go away for most people after 2 or 3 weeks. You may also feel tired when you leave the hospital to go home.

Most people who have had a heart attack take part in a cardiac rehab program.

 

Support Groups

See: Heart disease - resources

Expectations (prognosis)

After a heart attack, your chance of having another one is higher than if you never had a heart attack.

How well you do after a heart attack depends on the damage to your heart muscle and heart valves, and where that damage is located.

If your heart can no longer pump blood out to your body as well as it used to, you may develop heart failure. Abnormal heart rhythms can occur, and they can be life threatening.

Usually a person who has had a heart attack can slowly go back to normal activities, including sexual activity. Discuss your activity level with your health care provider.

References

  1. Anderson JL. ST segment elevation acute myocardial infarction and complications of myocardial infarction. In: Goldman L, Schafer AI, eds. Cecil Medicine. Philadelphia, Pa: Saunders Elsevier; 2011:chap 73.
  2. Antman EM. ST-segment elevation myocardial infarction: pathology, pathophysiology, and clinical features. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, Pa: Saunders Elsever; 2011:chap 54.
  3. Cannon CP, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, Pa: Saunders Elsever; 2011:chap 56.
  4. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients WithST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention(updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 Dec 1;120(22):2271-306. Epub 2009 Nov 18. [PubMed: 19923169]
  5. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American College of Emergency Physicians, Society for Cardiovascular Angiograpy and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57:1920-1959. [PubMed: 21450428]

Review Date: 6/22/2012.

Reviewed by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Michael A. Chen, MD, PhD, Assistant Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, Washington. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Copyright © 2013, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Copyright © 2013, A.D.A.M., Inc.

What works?

  • Sulphonylurea as sole therapy for patients with type 2 diabetes mellitusSulphonylurea as sole therapy for patients with type 2 diabetes mellitus
    Sulphonylureas are widely used for patients with type 2 diabetes mellitus. Sulphonylureas lower blood glucose by stimulating insulin secretion from the pancreas thereby increasing the insulin levels in the blood. Seventy‐two trials were included in the systematic review assessing the effects of sulphonylurea as sole therapy versus other comparators in patients with type 2 diabetes mellitus. A total of 22,589 participants were included. The number of participants randomised to a sulphonylurea was 9707 and the number of participants randomised to a comparator was 12,805. The duration of the interventions varied from 24 weeks to 10.7 years. All trials had deficiencies (risk of bias) and for the individual comparisons the number of participants were small, resulting in a high risk of random errors (play of chance). Data on mortality and diabetic complications were sparse and inconclusive. Stopping taking the antidiabetic drug due to adverse events were more common with alpha‐glucosidase inhibitors (for example acarbose) compared with second‐generation sulphonylureas (for example glibenclamide, glipizide, glibornuride and gliclazide), but the data were sparse. Severe hypoglycaemia was more common with second‐generation sulphonylureas compared with metformin and thiazolidinediones (for example pioglitazone), but again the data were sparse. Due to lack of data we could not adequately evaluate health‐related quality of life and costs.
See all (187) ...

Learn about...

  • Tips for reading the newsTips for reading the news
    Don’t automatically believe the headlines. Learn how to figure out which articles you’re going to believe and which you’re not.

MedlinePlus.gov links to free, reliable, up-to-date health information from the National Institutes of Health (NIH) and other trusted health organizations.

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk